The GEN II platform incorporates the first-ever directed-split-pool synthesizer with our fully automated AI-driven cell-free DNA cloning system for low-cost, high-diversity gene synthesis.
We have developed a proprietary process for assembling oligos into high complexity dsDNA sequences with great reliability and efficiency. This enables us to produce challenging sequences that many suppliers reject.
Our patented cell-free DNA cloning technology eliminates cumbersome plasmids and their inherent limitations from the production of synthetic DNA, resulting in a high-accuracy, high-purity final product.
